Inhibikase Therapeutics, Inc. - Common Stock (NQ:IKT)

2.115 +0.135 (+6.82%)
Streaming Delayed Price Updated: 1:26 PM EDT, Jul 7, 2026 Add to My Watchlist

Price and Volume

Detailed Quote
Volume 708,154
Open 1.980
Bid (Size) 2.110 (3,900)
Ask (Size) 2.120 (2,100)
Prev. Close 1.980
Today's Range 1.970 - 2.120
52wk Range 1.330 - 2.260
Shares Outstanding 31,056,238
Dividend Yield N/A

Performance

YTD
+8.5%
+8.5%
1 Month
+30.6%
+30.6%
3 Month
+18.2%
+18.2%
6 Month
+5.2%
+5.2%
1 Year
+9.6%
+9.6%

More News

Read More

Frequently Asked Questions

Is Inhibikase Therapeutics, Inc. - Common Stock publicly traded?
Yes, Inhibikase Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Inhibikase Therapeutics, Inc. - Common Stock trade on?
Inhibikase Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Inhibikase Therapeutics, Inc. - Common Stock?
The ticker symbol for Inhibikase Therapeutics, Inc. - Common Stock is IKT on the Nasdaq Stock Market
What is the current price of Inhibikase Therapeutics, Inc. - Common Stock?
The current price of Inhibikase Therapeutics, Inc. - Common Stock is 2.115
When was Inhibikase Therapeutics, Inc. - Common Stock last traded?
The last trade of Inhibikase Therapeutics, Inc. - Common Stock was at 07/07/26 01:26 PM ET
What is the market capitalization of Inhibikase Therapeutics, Inc. - Common Stock?
The market capitalization of Inhibikase Therapeutics, Inc. - Common Stock is 65.68M
How many shares of Inhibikase Therapeutics, Inc. - Common Stock are outstanding?
Inhibikase Therapeutics, Inc. - Common Stock has 66M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.